Portfolio comparison
Washington University in St. Louis vs Merck Sharp and Dohme LLC
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Washington University in St. Louis
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticalgene_editingoncology
Top Patents1 enriched
US 12564648· 2026
Gene Editing T-Cells to Fight CD7 Blood Cancers
Activity by Decade
2020s1
Company B
Merck Sharp and Dohme LLC
Patents indexed
1
Year range
2018
Most recent
2018
biotechpharmaceutical
Top Patents1 enriched
US 10028963· 2018
How to Treat Severe Lung Infections Using Ceftolozane and Tazobactam
Activity by Decade
2010s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.